• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Long COVID: US States with the Highest and Lowest Prevalence


Reports of previously healthy individuals experiencing lingering symptoms from an infection with SARS-CoV-2 started shortly after the beginning of the COVID-19 pandemic. Post-COVID conditions, or long COVID, include a range of new, returning, or ongoing health problems that persons may experience after infection, including fatigue, headache, rash, and depression or anxiety.

In the US, where exactly is long COVID the most prevalent? In a new report, researchers analyzed data from the US Census Bureau Household Pulse Survey for the week November 2-14, 2022. The Household Pulse Survey is a 20-minute online survey assessing the social and economic impact of the COVID-19 pandemic and other emergent issues on households across the US. Researchers ranked US states by the highest and lowest rate of respondents who received a positive COVID-19 test or diagnosis from a health care provider and reported having long COVID—defined for the purpose of the analysis as symptoms lasting ≥3 months. Below, find the 5 states with the highest percentage of residents with long COVID and the 5 states with lowest.

Related Videos
Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
Migraine Management Pearls for Primary Care with Neurologist Jessica Ailani, MD
Migraine-specific therapies belong in primary care setting, Jessica Ailani, MD
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
© 2024 MJH Life Sciences

All rights reserved.